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Objectives: The aim of this article was to identify and prospectively investigate
simulated ultrasound-guided targeted liver biopsy performance metrics as
differentiators between levels of expertise in interventional radiology.
Methods: Task analysis produced detailed procedural step documentation allowing
identification of critical procedure steps and performance metrics for use in a virtual
reality ultrasound-guided targeted liver biopsy procedure. Consultant (n514; male511,
female53) and trainee (n526; male519, female57) scores on the performance metrics
were compared. Ethical approval was granted by the Liverpool Research Ethics
Committee (UK). Independent t-tests and analysis of variance (ANOVA) investigated
differences between groups.
Results: Independent t-tests revealed significant differences between trainees and
consultants on three performance metrics: targeting, p50.018, t522.487 (22.040 to
20.207); probe usage time, p50.040, t52.132 (11.064 to 427.983); mean needle length
in beam, p50.029, t522.272 (20.028 to 20.002). ANOVA reported significant
differences across years of experience (0–1, 1–2, 3+ years) on seven performance
metrics: no-go area touched, p50.012; targeting, p50.025; length of session, p50.024;
probe usage time, p50.025; total needle distance moved, p50.038; number of skin
contacts, p,0.001; total time in no-go area, p50.008. More experienced participants
consistently received better performance scores on all 19 performance metrics.
Conclusion: It is possible to measure and monitor performance using simulation, with
performance metrics providing feedback on skill level and differentiating levels of
expertise. However, a transfer of training study is required.
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Training in interventional radiology (IR) uses the
traditional apprenticeship model despite recognised
drawbacks, e.g. difficulty articulating expertise, pressure
to train more rapidly [1], reduced number of training
opportunities. Moreover, it has been described as
inefficient, unpredictable and expensive [2, 3] and its
suitability for training has been questioned owing to
there being no mechanism for measuring post-training
skill [4]. There is an increasing need to develop
alternative training methods [5]. Using simulators to
train offers numerous benefits, including gaining experi-
ence free from risk to patients, learning from mistakes
and rehearsal of complex cases [6]. IR is particularly
appropriate for simulator training as skills, such as
interpreting two-dimensional radiographs or ultrasound
images, can be reproduced in a simulator in the same
way as in real-life procedures.
There is increased use of medical virtual reality
simulators, with some validated to show improved
clinical skills, e.g. laparascopic surgery [7], colonoscopy
[8] and anaesthetics [9]. However, within IR no simulator
has met this standard [5, 6, 10], with validation studies
typically failing to discriminate accurately between
experts and novices [11], although differences have been
observed [12]. Length of time to complete procedures on
simulators is a frequently reported expertise discrimi-
nator [6] but there is a worrying lack of emphasis on
the number of errors made or other clinically relevant
parameters. A recent review [6] reported ‘‘fundamental
inconsistencies’’ and ‘‘wide variability in results’’ in
validation studies, concluding that the analysis of errors
and quality of the end product should be the focus of
assessment. The authors proposed that, to fully develop
and validate simulators, there is a need for task analysis
(TA) to deconstruct individual procedural tasks followed
by metric definition and critical performance indicator
identification. This echoes previous calls for expert
involvement in simulator design [13].
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To the best of our knowledge, no IR simulators have
been developed through the use of TA of real-world
tasks despite the critical role of such techniques in
training development and system design for the past 100
years [14]. TA identifies knowledge and thought pro-
cesses supporting task performance, and the structure
and order of individual steps, with particular relevance
in deconstructing tasks conducted by experts [15, 16]. TA
techniques are increasingly being used as a medical
educational resource, e.g. the development of surgical
training [17] and the teaching of technical skills within
surgical skills laboratories [18].
Using task analysis, this research identified and pro-
spectively investigated simulated ultrasound-guided tar-
geted liver biopsy performance metrics as differentiators
between levels of expertise in IR.
Methods and materials
The research method incorporated three objectives:
N Produce a detailed hierarchical and cognitive TA of an
ultrasound-guided, targeted liver biopsy procedure to
inform simulator design.
N Identify the critical performance steps (CPSs) that
are key to the safe completion of the procedure
and to inform measurement of performance on the
simulator.
N Perform construct validation comparing novice and
expert performance on the simulator.
These objectives are described in more detail below,
followed by technical information on simulator design.
Task analysis
Data were collected through discussions with clinician
collaborators, observation of procedures, video-recording
procedures and interviews.
Discussions with clinical collaborators informed on the
nature and aim of the procedure. Observing a small number
of IR procedures allowed understanding of the complexity
of the tasks, equipment and environment of the IR suite
prior to the acquisition and observation of video data.
Ethical and research governance approval was granted
for video data collection from the Liverpool Research
Ethics Committee. Data were collected at two UK
hospitals and a total of four liver biopsy videos obtained.
Patients’ written informed consent was obtained.
12 interviews were conducted. A wide selection of experts
was assured through interviews at clinical sites in the UK
and at three high-profile IR conferences: Cardiovascular
and Interventional Radiological Society of Europe (Copen-
hagen, September 2008) British Society of Interventional
Radiology (Manchester, November 2008) and Society of
Interventional Radiology (Washington, March 2008; San
Diego, March 2009). Interviewees were identified as subject
matter experts (SMEs) by their professional bodies. SMEs
were asked to describe the liver biopsy procedure and were
questioned about the following: aims and stages of the
procedure, tools and techniques, ‘‘decision points’’, potential
complications and the amount of risk individual steps in a
procedure pose to a patient.
Interviews were semi-structured to allow for explora-
tion of points raised by SMEs and lasted approximately
1 h. Salient points and issues were explored in more detail
with subsequent SMEs. SMEs were asked to justify the use
of certain techniques and decisions, and the information/
cues used to guide this decision-making.
While data collection was ongoing, a first draft of
the TA for the liver biopsy procedure was produced.
Observable actions were identified from video data and
included in task descriptions. Further information was
taken from the interviews including detailed descriptions
of the procedure; potential errors/complications, includ-
ing their identification and prevention; cues that indicate
procedure success, safety and completion; decisions
made; and the information that guided these decisions.
Areas needing clarification were identified and explored
in subsequent interviews. Throughout this process, the
TA was redrafted and refined. Drafting the document in
this manner provided a fully developed tool.
Critical performance steps
The TA was used in the design of a questionnaire to
provide data to identify the CPS of the liver biopsy
procedure. Respondents rated each step of the TA on
seven-point Likert scales ranging from very strongly
disagree to very strongly agree in two areas: (a) whether
the step is of critical importance to a successful
procedure; (b) whether the step poses a high risk to a
patient. Eight subject matter experts completed the CPS
questionnaire. Interview transcripts were reviewed to
identify the critical parts of the procedure as discussed
by SMEs. Performance metrics relating to the CPS were
identified and incorporated in the liver biopsy simulator
to allow measurement of participant performance.
Construct validation
Construct validation investigated the use of CPSs and
related performance metrics to measure performance and
to differentiate across expertise. Ethical and research
governance approval was granted by the Liverpool
Research Ethics Committee and the study was conducted
in three UK hospitals. SMEs and IR trainees participated in
the study. 41 respondents (SMEs, n514; trainees, n526;
unreported status, n51) participated and provided full
informed consent. All participants completed the simu-
lated liver biopsy procedure and their performance was
assessed with the performance metrics. Independent t-tests
investigated whether SMEs/consultants produced better
performance metrics on the simulator than trainees.
Analysis of variance was used to investigate performance
differences across the number of years of experience in IR.
Simulator design
The simulator is composed of (1) a mannequin, used to
initially scan a patient and perform a skin nick with a
scalpel; (2) a virtual environment to display the patient
S J Johnson, C M Hunt, H M Woolnough et al
556 The British Journal of Radiology, May 2012
while inserting a needle; (3) two haptic devices to replicate
the medical tools; and (4) a simulated ultrasound
(Figure 1). Each component is detailed as follows: (1) the
mannequin has a human torso shape, and motors
reproduce the breathing behaviour. It is linked with two
sensors to track the positions of the faked ultrasound probe
and the scalpel. (2) The virtual environment displays a
three-dimensional (3D) patient, with 3D glasses on a semi-
transparent mirror. It includes organ deformations and the
visualisation of both the needle and the ultrasound probe.
(3) The first haptic device simulates the ultrasound probe
action with a stiff contact feedback when touching the
external skin and a simulated ultrasound rendered
according to the position and orientation of the device.
The second haptic device simulates the needle with force
feedback based on the insertion behaviour while penetrat-
ing through soft tissue. Its position is used to compute the
metrics. (4) The ultrasound is displayed on a monitor and is
a computer-based simulation based on the organ geometry
associated with their deformation.
Results
Task analysis
The first column of Table 1 shows a short segment of
the ultrasound-guided targeted liver biopsy TA; the
complete document involves 174 procedural steps, and
therefore is not reproduced in full.
Many procedural details derived from the TA were
included in the simulator to increase the immersion and
procedure realism. Two examples are detailed here. First,
the influence of respiration on the procedure was
incorporated through development of a breathing model
to allow participants to see organ motion on the ultrasound
and to have needle oscillation in the 3D environment.
Second, the haptic feedback was developed to fully
reproduce the needle insertion steps: skin perforation,
various soft-tissue behaviour and liver capsule penetration.
Critical performance steps
The CPS questionnaire responses provided frequency
data to assist identification of those aspects of the
procedure that should be measured to inform on
performance in the simulator. More detailed statistical
analysis of the quantitative data was not appropriate
owing to the restricted sample size (n58). If a step was
rated as either important to successful completion of the
procedure or carrying significant risk to the patient, or
both, by the majority of experts (i.e. by at least five
experts) it was highlighted in the TA documentation. A
total of 30 CPSs were identified for the liver biopsy
procedure. The first column of Table 1 indicates the
quantitative CPS for this segment of the liver biopsy
procedure.
Reviewing the interview transcripts allowed the identi-
fication of 13 aspects of the procedure that were described
by experts as being critical to successfully and safely
completing the procedure. These corresponded with the
important and risky steps identified through the CPS
questionnaires (the second column of Table 1 reports
qualitative CPSs). It was not unexpected to identify fewer
CPS points in the qualitative data collection as verbal
descriptions of procedural actions are less detailed than a
documented TA. One qualitative CPS therefore incorpo-
rates a number of quantitative CPSs.
A final TA document was produced that detailed
the procedure steps and the quantitative and qualitative
CPSs. This document informed simulator development.
Decisions on the inclusion of performance metrics were
made in relation to (1) the CPS identified by the procedure
detailed above and (2) the capability of the simulator to
measure performance on these steps.
Where possible, each CPS was measured directly.
However, some aspects of the procedure were not
represented in the simulator, yet had been identified by
experts as CPSs. Care was therefore taken to ensure that
these steps were represented in the simulator despite not
being fully simulated. For example, ensure that ‘‘there
are no air bubbles in a syringe of local anaesthetic’’ was
brought to the attention of the participant through the
use of a ‘‘check-box’’. This ensured that key procedural
steps were not fully omitted.
19 quantitative performance metrics were included in
the simulator (Table 2). To provide further context, the
third column of Table 1 indicates the performance metric
for each step of the procedure. It was therefore possible to
produce accurate measurement of participant performance
on each of these 19 performance metrics. Participants with
differing levels of expertise in IR were then compared,
allowing discriminant validation of the simulator and the
selected performance measures.
It was predicted that performance on the simulator
would relate to IR competency. Specifically, participants
Figure 1. Ultrasound-guided liver
biopsy simulator components. 3D,
three-dimensional.
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who were more experienced in real-life IR procedures
would perform better on the simulator.
Detailing each technical implementation of the metrics
would be too tedious for the reader; instead, only the
first two are explained here: number of no-go areas touched
and targeting quality. First, a list of anatomical no-go
areas was obtained from the SME interviews and a
detection collision algorithm was used to check if the
virtual position of the needle tip touched any of these
areas during the process. Summarising the results on the
Table 1. Segment of liver biopsy task analysis with quantitative and qualitative CPS
Procedure steps quantitative CPSsa Qualitative CPSs Performance metric
Inject locally [this produces a bleb on the skin
which looks like a nettle sting and gives
near (0–2 min) instantaneous anaesthesia].
1–2ml initially
Identify access point and
inject locally: in correct
position for access given
trajectory and approach
Tick box
Approximately 1 cm deep skin nick at planned
incision site. The blade can be pushed
directly down as planned biopsy site
has been identified, so there is no danger
of damaging anything underneath the
skin. A deeper cut reduces any resistance
when the needle is inserted
Identify access point and
nick skin in the correct
position for access given
trajectory and approach
Tick box
NOTE: Skin nick is made to facilitate
needle insertion. It is more difficult to
insert the biopsy needle without the skin nick
Looking at the ultrasound screen, roll the
probe back and forth on the incision
site until the planned biopsy site is identified
Target visible as a percentage
of total probe usage time
Note the depth of the planned biopsy site
using the markers on the ultrasound screen
Simulated ultrasound screen shows
measurement markers
Pick up the biopsy needle from the green
sheet—make a note of the measurement
markers on the needle to identify how
deep this needle is going to be inserted
Not measured
Holding the needle shaft, begin
to insert the needle into incision
Time on target (i.e.
to lesion with needle)
Position needle and probe at planned
biopsy site in the same plane (to ensure that
all necessary information can be
viewed on the ultrasound screen)
Triangulation correct, i.e.
angle of probe and
angle of needle correct
to reach target
Time on target (i.e.
to lesion with needle)
Average needle
length in beam
Needle in beam as a percentage
of total probe usage time
Slowly advance the needle towards the
planned biopsy site, constantly viewing
the ultrasound image to guide
orientation and progress
NOTE: If utilising an intercostal approach,
aim the needle over the top of the
lower rib, as opposed to the bottom of
the upper rib, to avoid hitting nerves
Co-ordinate hands and images:
keep length of needle on
screen at all times. NOTE:
in large patients the needle
needs to be inserted before
it can be seen, owing to angle
Time on target (i.e. to lesion with
needle)
Average needle length in beam
Needle in beam as a percentage of
total probe usage time
Needle tip in beam as a percentage
of total probe usage time
No-go area touched
Total time in no-go areas
Number of tissues encountered
Target visible as a percentage of
total probe usage time
Continue advancing the needle in this way
until the planned biopsy site is reached
(the needle should be positioned just
short of the planned sample site; if a
tumour is being biopsied the needle needs
to be at the edge of the tumour); be
guided by both the image and your
knowledge of the depth of the planned
biopsy site
Watch needle in real time on
it is as ultrasound introduced
into the liver
Time on target (i.e. to lesion with
needle)
Average needle length in beam
Needle in beam as a percentage of
total probe usage time
Needle tip in beam as a percentage
of total probe usage time
No-go area touched
Total time in no-go areas
Number of tissues encountered
Target visible as a percentage of
total probe usage time
Targeting quality
Number of biopsy samples taken
CPS, critical performance steps.
aSteps: in bold were rated as important and carrying significant risk if performed incorrectly; steps in italics were rated as
important but were not considered a significant risk.
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whole body gives the total number of no-go areas
touched. Second, the simulator records the distance d
between the centre of the sphere representing the tumour
and the position of the virtual needle when the haptic
device button is pushed (representing the firing of the
biopsy needle). The targeting quality is computed as
follows:
targeting quality~
00necrosis debris00 if dv5
00perfect00 if dv15
00some cells00if dv20
00no pathology00 if d~else
8>><
>>:
Construct validation
Construct validation studied the performance of IR
consultants (n514) and trainees (n526). Table 3 reports
the significant differences revealed for three of the
performance metrics: targeting; probe usage time; and
mean needle length in beam. These were in the
expected direction, with consultants achieving better
performance metrics than trainees. Specifically, con-
sultants obtained significantly better ‘‘biopsy samples’’
used the probe significantly less (suggesting, they were
more proficient and better able to locate the target) and
had significantly more needle length in the beam
(indicating greater proficiency in needle identification
and tracking). While significant differences were
shown in just 3 metrics, the mean scores for the
remaining 16 performance metrics showed a consistent
trend of better performance for consultants than
trainees.
Performance was also compared across a number of
years of experience: 0–1 years (first-year trainees), n58;
1–2 years, n513; 3 or more years (including final-year
trainees and consultants), n510. Participants who did
not report their years of experience were removed from
the data set prior to analysis.
Table 4 reports the significant differences revealed
across years of experience for seven of the performance
metrics: number of no-go areas touched; targeting; length
of session; probe usage time; total needle distance moved;
number of skin contacts; and total time in no-go area.
Each of these was in the expected direction. Inspection of
the mean scores for all performance metrics revealed that,
although only these seven were significant, the perfor-
mance metrics again followed a predictable pattern
across experience. That is, more experienced participants
consistently received better scores on each of the
performance metrics.
Tukey’s post hoc test showed that there were differ-
ences between the 0–1 years’ experience and 3 or
more years’ experience metrics on all seven significant
performance metrics. Significant differences were also
found between 0–1 years’ experience and 1–2 years’
experience on two of the metrics, number of skin contacts
and total time in no-go area.
The acceptability and utility of the simulator to
participants is indicated by 84% of participants agreeing
that it would be useful in learning the steps of a
procedure, and 81% believing that it would be useful for
procedure rehearsal. The quality of the feedback provided
by the simulator was also indicated, with 80% of
participants reporting the feedback as accurate.
Discussion
This paper has described the deconstruction of the
ultrasound-guided targeted liver biopsy procedure using
TA techniques, resulting in detailed documentation of the
steps required for successful completion of the proce-
dure. Additionally, those steps of most importance to the
success of the procedure and in managing risk to the
patient were identified (i.e. the CPS). Performance metrics
that allowed the measurement of these CPSs were
incorporated into the simulated procedure, and thus
provided a means by which to measure and monitor
participant performance. Comparing performance on the
simulated liver biopsy, both between trainees and
consultants and between differing lengths of experience
in IR, revealed significant differences on a total of eight
performance metrics. Each of these was in the expected
direction, with more experienced participants consis-
tently performing better than less experienced partici-
pants. Furthermore, a consistent trend was revealed
across all performance metrics, i.e. more experienced
participants received better scores on all 19 performance
metrics. The results indicate that the identified perfor-
mance metrics can accurately discriminate for expertise,
and that number of years of experience in IR is a more
informative level of comparison than a simple trainee/
consultant split.
A strength of the study is the care taken to ensure that the
simulated procedure was based upon real-life procedures,
with the TA and CPS identified through subject matter
expert input. Simulator content and development was
guided and underpinned by expert knowledge, and thus
allowed for theoretically based performance evaluation
Table 2. Liver biopsy performance metrics incorporated into
simulator
Liver biopsy performance metrics
Number of no-goa areas touched
Targeting quality (no sample, no pathology, some cells, perfect)
Number of attempts
Number of biopsy samples taken
Length of session(s)
Probe usage time(s)
Time on target [needle accurately directed towards lesion(s)]
Probe usage as a percentage of total procedure time (%)
Average needle length in beam (mm)
Target visible as a percentage of total probe usage time (%)
Needle in beam as a percentage of total probe usage time (%)
Needle tip inbeamasapercentageof total probeusage time (%)
Total probe distance moved (mm)
Average probe distance moved (mm)
Total needle distance moved (mm)
Average needle distance moved (mm)
Number of skin contacts
Number of tissues encountered
Total time in no-go areas (%)
aNo-go area: an anatomical region where needle penetra-
tion would represent a risk for complication or patient
discomfort.
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using evidence-based components. The need for expert
input into simulator design is recognised [13] and identified
as lacking in existing IR simulation research [6]. Using this
approach ensured that the simulated procedure was
comprehensive and realistic, with the monitoring of
performance focused upon the most important aspects of
the procedure in terms of successful completion and
management of risk to the patient. The significant differ-
ences that were reported in the performance metrics indicate
that it is possible to assess expertise through performance on
the simulator. This further suggests that training on the
simulator would allow experience to be gained on critical
elements of the procedure, with a subsequent improvement
in performance to be anticipated following practice.
This is the first study of IR simulation that has
accurately discriminated across expertise on a number
of performance metrics. It is therefore an important
addition to existing research into IR simulation that has
to date failed to discriminate expertise, although differ-
ences across expertise have been reported [11, 12].
Length of time to complete a simulated procedure has
previously been found to discriminate expertise [6, 19]
and was confirmed here. The main contribution of the
present study, though, is in the identification of clinically
relevant parameters and errors that can discriminate
expertise (e.g. total needle distance moved, number of
no-go areas touched). Trainees thus receive performance
feedback on those areas that allow an assessment of
procedural quality, i.e. analysis of errors and the quality
of the end product [6].
The research reveals that it is possible to measure and
monitor performance on a liver biopsy procedure using
simulation, with performance metrics providing feedback
on various aspects of the procedure. This should enable
participants to identify those elements of a procedure they
have mastered or that require further skill development.
This is likely to be useful during training, particularly given
the known difficulties in gaining significant practice of core
skills in patients. Simulators have the potential to facilitate
training in areas where traditional training is failing to keep
up with demand and have proven to be useful in the
medical field in other areas (e.g. laparoscopy, colonoscopy).
The results from the current study suggest that simulation
may also be useful in training key skills in IR. It was also
reported that the majority of participants believed the
simulator to be an acceptable and useful training tool. It is
not proposed that simulation could, or indeed should,
replace existing training in IR, which is a profession that
encompasses far more skills than simulators can currently
inform on (e.g. decision-making, complexity and interac-
tions in the real environment). Nevertheless, this study,
alongside the increasing interest and research into simula-
tion in IR and the existing problems with current training
such as lack of opportunity to train and pressure to train
Table 3. Consultant and trainee performance metric comparison
Performance metric Participant Mean Standard deviation t-test p-value 95% confidence interval
Targetinga Trainee 0.96 1.27 22.487 0.018 22.040 to 20.207
Consultant 2.08 1.31
Probe usage time Trainee 699.32 335.86 2.132 0.040 11.064 –427.983
Consultant 479.80 255.20
Mean needle
length in beam
Trainee 0.03 0.02 22.272 0.029 20.028 to 20.002
Consultant 0.04 0.02
aTargeting: 0, no sample; 1, no pathology; 2, some cells; 3, perfect.
Table 4. Comparison of performance metrics across years of experience
Performance metric Experience (years) Mean Standard deviation F-value p-value
Number of no-goa areas touched 0–1 3.75 2.05 5.218 0.012
1–2 2.00 1.35
3+ 1.33 1.41
Targetingb 0–1 0.38 0.74 4.258 0.025
1–2 1.25 1.42
3+ 2.11 1.27
Length of session 0–1 866.18 201.60 4.277 0.024
1–2 690.25 396.20
3+ 447.29 227.09
Probe usage time 0–1 809.82 255.88 4.209 0.025
1–2 645.65 377.43
3+ 400.96 211.60
Total needle distance moved 0–1 24.15 10.16 3.691 0.038
1–2 16.10 8.71
3+ 12.80 8.34
Number of skin contacts 0–1 58.00 14.57 10.792 ,0.001
1–2 33.69 22.26
3+ 19.40 11.74
Total time in no-go area 0–1 50.32 27.22 5.812 0.008
1–2 19.81 34.38
3+ 7.13 12.34
aNo-go area: an anatomical region where needle penetration would represent a risk for complication or patient discomfort.
bTargeting: 0, no sample; 1, no pathology; 2, some cells; 3, perfect.
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more rapidly [6], strongly indicates that if developed and
used appropriately, IR simulation could prove to be an
invaluable and highly informative training tool. We agree
with other authors [e.g. 6, 13] that simulation should
augment rather than replace existing methods.
There are many advantages to simulator training
based on task-specific information that has been appro-
priately validated. Trainees will have the opportunity to
practise a standardised task with a high degree of
realism; receive feedback on their performance through
the use of validated assessment metrics derived from
experts; and gain basic skills that can become automated
before procedures are conducted with real patients.
Further advantages include an absence of the ethical
issues of training in patients and animals, the opportu-
nity for a simulator to cover a number of anatomically
different procedures and the use of patient-specific
simulations that allow practice of a complex procedure
prior to actual performance in the patient. In addition to
these benefits, it has been proposed [13] that simulators
have the potential to assist with aptitude testing
advanced skills training career-long training board
examination and credentialing. There are of course a
number of disadvantages, the most obvious of which is
the cost. Simulator development is time consuming and
expensive. Buying a simulator for use by trainees is very
expensive and in 2007 was estimated at between $100 000
and $200 000 with additional annual service costs of
between $10 000 and $16 000 [5]. Day-to-day costs of
using simulators can also be significant, for example
transport and maintenance costs. Some of these costs
may, however, be reduced by cost-effective technologies
from the games industry.
A limitation of the study is the small number of
participants, and further work with larger sample sizes is
desirable to confirm the most useful performance metrics
and to develop ‘‘norm’’ scores to provide performance
benchmarks against which trainee scores can be com-
pared. Furthermore, although the results of the current
study provide evidence of the discrimination of expertise
by use of the simulator performance metrics, it does not
prove that skills can be acquired in the simulator. A
transfer of training study of any simulator, is needed to
provide evidence of skills acquisition on the simulator,
and of the transferability of those skills to real-world
procedures in patients. Evidence of transfer of training in
simulation should be a prerequisite for adoption as a
training tool.
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